FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

Hantavirus Risk to US Public Remains Low, CDC Says

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Chronic Cough Tied to Greater Healthcare Burden

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Gut Microbe Blooms Linked to Lupus Kidney Disease

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis endotype characterized by platelet activation and neutrophil degranulation.

Scarring Alopecias More Common in Black People, Urban Areas

Primary lymphocytic cicatricial alopecias disproportionately affect women, Black individuals, and urban dwellers, a study finds.

Britain to Bring 10 People to UK for Precautionary Isolation After Hantavirus Outbreak

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Tests in Italy, Spain Come Back Negative in Global Hunt for Hantavirus

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis endotype characterized by platelet activation and neutrophil degranulation.

Primary lymphocytic cicatricial alopecias disproportionately affect women, Black individuals, and urban dwellers, a study finds.

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

News All Time

US Says 18 Passengers Flown Back After Hantavirus Outbreak on Ship

U.S. Department of Health and Human Services officials said on Monday that 18 passengers from the luxury cruise ship hit by a hantavirus outbreak were flown back to the...

Hantavirus Protocol Breach At Dutch Hospital as Medics Race to Curb Spread

A Dutch hospital has quarantined 12 staff members as a preventive measure after blood and urine from a hantavirus patient were handled without observing strict protocols, as...

26-Year-Old Man With Posttransfusion Hyperhemolysis

Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.

Language Models as Emergency Room Decision Support

A Science study finds modern large language models often match or exceed physicians in emergency room diagnostic decisions, especially at initial triage, but real-world trials remain essential.

Exclusive-Kennedy's Health Officials Explored US Ban Of Some Widely Used Antidepressants, Sources Say

U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F....

Early Trauma May Shape Outcomes in Childhood-Onset Lupus

Adverse childhood experiences are common in children with systemic lupus erythematosus and are linked to higher odds of neuropsychiatric lupus, a cohort study finds.

Reduced Kidney Function Tied to Lower Remission Rates in RA

For patients with rheumatoid arthritis and reduced kidney function, remission after drug therapy is less likely than for patients with preserved kidney function.

Four Factors Keep ‘At-Risk’ Group Arthritis-Free at 10 Years

People with ‘good’ prognostic factors at baseline are less likely to progress to rheumatoid arthritis at 5 and 10 years after presentation, a cohort study finds.

MHRA Approves New Prophylactic for Rare Swelling Disorder

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

FDA Seeks Advice on Researching Drug Risks in Pregnancy

The FDA held a workshop on ways to improve collection of safety data on medicines used during pregnancy and released guidance for companies on postapproval pregnancy safety studies.

Mental Health Conditions Tied to Cancer Risk, Study Reveals

Depression, anxiety, and bipolar disorders are associated with increased risks for overall and site-specific cancers, a population-based study reports.

Gestational Weight Gain May Shape Allergic Disease Risk

Children may have higher odds of developing asthma, rhinitis, and allergic sensitization if their mothers have excessive weight gain during gestation, a study shows.

Small Study Shows One-time Cell Therapy Can Control HIV Infection

Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded in controlling the infection in a small first-in-human study, but researchers said...

New Paper Highlights Evidence for Congenital Lyme Disease

Evidence suggests Borrelia burgdorferi can cross the placenta and may be associated with adverse pregnancy outcomes.

Optimizing COVID-19 Care for Hospitalized Patients

Optimizing COVID-19 Care for Hospitalized Patients

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Recommended News For You

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

Clinical trial sees dramatic results using radiation to treat breast cancer

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

Study: For predicting breast cancer, AI performs better than traditional risk models.

Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Recommended Articles For You

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools 

Case Study: Genomic Medicine in Precision Oncology 

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More People Than Previously Believed Have Schizophrenia.

2.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

3.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

4.

Including Bereavement in the Care Continuum.

5.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Exploring the Potential of Bendamustine in Cancer Treatment

3.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

4.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

5.

Everything You Need to Know About CA 19-9 and Cancer Diagnosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot